Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
No human trial has shown Akkermansia to be a weight-loss treatment, and the same trial did not meet its main insulin-sensitivity goal across the group as a whole, with benefits showing up mainly in people who started with low Akkermansia levels or who had prediabetes
PMCID: PMC2795722 This product is strictly for research/laboratory use only
With the end of insurance coverage, people who have spent decades trying to lose weight, including by undergoing surgery to shrink their stomachs, are scrounging for ways to afford to pay out-of-pocket for GLP-1s, or exercising and counting calories in the hopes of keeping the weight off without the drugs
Titrating semaglutide helps patients manage, but not necessarily prevent, common semaglutide side effects like dizziness
US$ 25.44
US$ 26.59
US$ 24.95
US$ 22.87
US$ 28.98
